Estrella Immunopharma Files Q1 2025 10-Q
Ticker: ESLAW · Form: 10-Q · Filed: May 14, 2025 · CIK: 1844417
| Field | Detail |
|---|---|
| Company | Estrella Immunopharma, INC. (ESLAW) |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
Estrella Immunopharma filed its Q1 2025 10-Q. All systems go.
AI Summary
Estrella Immunopharma, Inc. filed its quarterly report for the period ended March 31, 2025. The company, formerly known as TradeUP Acquisition Corp., is focused on biological products. Its principal executive offices are located at 5858 Horton Street, Suite 370, Emeryville, California.
Why It Matters
This filing provides investors with an update on Estrella Immunopharma's financial and operational status for the first quarter of 2025, crucial for understanding the company's performance in the biotechnology sector.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Numbers
- 20250331 — Fiscal Period End (The report covers the quarterly period ending on this date.)
- 86-1314502 — EIN (Employer Identification Number for Estrella Immunopharma, Inc.)
Key Players & Entities
- Estrella Immunopharma, Inc. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- TradeUP Acquisition Corp. (company) — Former company name
- 5858 Horton Street, Suite 370, Emeryville, California (location) — Principal executive offices address
- 001-40608 (other) — Commission File Number
FAQ
What is the primary business of Estrella Immunopharma, Inc.?
Estrella Immunopharma, Inc. is primarily involved in biological products, as indicated by its Standard Industrial Classification code [2836].
When was the company formerly known as TradeUP Acquisition Corp.?
The company's former name was TradeUP Acquisition Corp., and the date of its name change to Estrella Immunopharma, Inc. was February 4, 2021.
What is the address of Estrella Immunopharma's principal executive offices?
The principal executive offices of Estrella Immunopharma, Inc. are located at 5858 Horton Street, Suite 370, Emeryville, California, 94608.
What is the Commission File Number for Estrella Immunopharma, Inc.?
The Commission File Number for Estrella Immunopharma, Inc. is 001-40608.
What is the fiscal year end for Estrella Immunopharma, Inc.?
The fiscal year end for Estrella Immunopharma, Inc. is December 31st.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Estrella Immunopharma, Inc. (ESLAW).